Curriculum Vitae

Blood Products Advisory Committee

Roshni Kulkarni, M.D.

Office Address Michigan State University
Department of Pediatrics and Human Development
B-220 Clinical Center
138 Service Road
East Lansing, MI 48824-1313
--------------------
Citizenship: ---------
Present Position: Professor, Department of Pediatrics and Human Development
Director, Pediatric & Adolescent Hematology/Oncology
College of Human Medicine
Michigan State University

Education:

l973 - l975 Pediatric Hematology/Oncology Fellowship, Children's Hospital of Michigan and
Wayne State University School of Medicine, Detroit, Michigan
l97l - l973 Pediatric Residency, Children's Hospital of Michigan and Wayne State University School of Medicine, Detroit, Michigan
l970 - l97l Pediatric Residency, Osmania University, Niloufer Hospital, Hyderabad, India
l969 - l970 Internship, St. Lukes Hospital, Denver, Colorado
l968 - l969 Internship, Osmania General Hospital, Hyderabad, India
---------- M.D. Degree, Osmania Medical College, Indian Institute of Medical Sciences, Hyderabad India

Professional Appointments:

1992 - Present Professor, Pediatric Hematology/Oncology, Pediatrics and Human Development, Michigan State University, College of Human Medicine.
Division Chief, Pediatric and Adolescent Hematology/Oncology
Medical Director (Pediatrics) Michigan State University Center for Bleeding and Clotting Disorders
l984 - 1992 Associate Professor, Pediatric Hematology/Oncology, Pediatrics and Human Development, Michigan State University, College of Human Medicine.
l977 - l984 Assistant Professor, Pediatric Hematology/Oncology, Pediatrics and Human Development, Michigan State University, College of Human Medicine.
1977 - 1978 Assistant Director, American Red Cross, Lansing, Michigan
l976 - l977 Assistant Director of Staff, American Red Cross, Children's Hospital of Michigan, Detroit, MI.
l975 - l976 Assistant Professor of Hematology, Niloufer Hospital, Institute of Child Health, Hyderabad, India

Career Development:

1996 Hemophilia Treatment in the Age of Genetic Engineering. Bayer Corporation. San Francisco. California, Nov. 1996.
1991 AAMC Women in Medicine Professional Development Seminar
1989 Michigan State University, Primary Care Faculty Development
1987 Georgetown University, Intensive Bioethics course XIII

Certification:

Diplomate of American Subspecialty Board, Pediatric Hematology/Oncology, December l978
Diplomate of American Board of Pediatrics, July, l975
FLEX -- Michigan, September l975.
American Medical Qualification Examination, E.C.F.M.G., Number l08-728-7, February l2, l969.

Honors and Citations:

  1. Distinguished faculty award, College of Human Medicine May 2004
  2. Cited in Sparrow news Feb 2004
  3. Featured faculty of the Department of Pediatrics and Human Development Dec. 2003: On the web at http://www.msu.edu/user/phd/index.htm
  4. Physician of the Year: National Hemophilia Foundation's Award of excellence, Nov. 2003
  5. Cited in the Lansing State Journal, Dec 22nd 2003, Towne Courier.
  6. Cited in the Hemophilia Foundation of Michigan Press Dec 2003.
  7. Nominated for Distinguished Faculty Award for the university 2003
  8. Cited in an article in "Noise", a weekly magazine published by Lansing State Journal published 11/19/2003 called "Menstruation under the microscope. Lets talk periods" pages 18-19. editor : Escobar L.
  9. East meets West: Profile of Roshni Kulkarni. . HEMAware, 7. (6) 2002.
  10. Cited in Hemalog article on "Head trauma in Hemophilia". 2002
  11. The William B. Weil, Jr. M.D., FAAP Endowed Distinguished Pediatric Faculty Award, April 1999
  12. Alpha Omega Alpha Honor Medical Society (AOA), MSU Gamma Chapter, November 1998
  13. Awarded Certificate for Excellence in Teaching, 1996 (MSU/EWSH Pediatric Residency Program)
  14. Awarded Certificate for Excellence in Teaching, 1993 (MSU/EWSH Pediatric Residency Program)
  15. Michigan State University, College of Human Medicine Distinguished Clinician Award, May, 1991
  16. Awarded Certificate for Excellence in Teaching, l987 (GMEI Residency Training)
  17. Awarded Certificate for Excellence in Teaching by pediatric residents, 1980 (GMEI)
  18. Cited in a book called "They Accepted the Challenge" by Kuntzleman CT and Cryderman L. St. Martin's Press, New York, NY 10010, 1980
  19. Awarded Certificate by Institute of Child Health, Niloufer Hospital, Hyderabad, India, in recognition of outstanding contribution to the welfare of women and children, July, l979

Volunteer Services

1997 Mentor for minority freshman, Michigan State University
1997-1998 India Cultural Association volunteer at Everett High School- teach students science on Saturday mornings.

Memberships:

International Society of Thrombosis and Haemostasis
Michigan Society of Hematology Oncology
World Federation of Hemophilia
National Hemophilia Foundation
Hemophilia and Thrombosis Research Society
American Society of Pediatric Hematology/Oncology, l98l to present.
Central Michigan Pediatric Society, l98l to 1982.
American Society of Hematology, l980 to present.
Michigan State Medical Society, l978 to 1979.
American Academy of Pediatrics, l970 to 1989
Michigan State University Cancer Consortium, 1989 to present.

Medical Advisory Boards/Consultant:

1999 - Present Medical & Scientific Advisory Committee, National Hemophilia Foundation, Midwest representative
1993 - 1996 Medical & Scientific Advisory Committee, National Hemophilia Foundation, Region 10 Representative
l980 - Present Hemophilia Foundation of Michigan
1988 - Present Michigan Department of Public Health, Pediatric Subspecialty Advisory Board
2002 - 2002 Consultant Aventis-Behring Corporation
2002 - Present Consultant /Speakers Bureau Baxter Corporation. North American Clinicians Advisory committee
2002 - Present Speakers Bureau NovoNordisk Corporation
1992 - 1995 Chair, Medical Advisory Board, Hemophilia Foundation of Michigan
1994 - 1997 Medical Director, Special Days Camp for children with cancer
1991 - 1992 Co-Chair, Medical Advisory Board, Hemophilia Foundation of Michigan
1989 - 1990 Children's Leukemia Foundation of Michigan
1986 - 1990 Children's Leukemia Foundation of Michigan
l979 - l982 Children's Leukemia Foundation of Michigan
l978 - 1989 American Red Cross, Lansing Chapter

Board member:

2005 Hospice of Lansing
2002 - Present Board Hemophilia and Thrombosis Research Society (national election)
1989 - Present Special Days Camp for Children with Cancer
1988 - 1993 Children's Leukemia Foundation of Michigan
1980 - 1982 Hemophilia Foundation of Michigan

Committees
University Committees

2005 - Reappointment Promotion and Tenure committee, College of Human Medicine
2003 - Clinical Domain Group (PBL) committee
2001 - 2003 Admissions Committee, College of Human Medicine
1999 - Present Alpha Omega Alpha faculty selection committee
1999 - 2001 International Studies/Programs
2000 Grievance committee
2000 - 2003 Michigan Partnership for the Advancement of End-of-Life care curriculum committee
1995 -1999 Cancer Core Grant Committee
1995 - 1999 University Committees on Academic Council/Faculty Council
1994 - 1996 Department Representative, Clinician's Council, and Michigan State University
1990 - 1992 Women's Advisory Committee to the Dean
1988 - 1990 Credentials/Privileges Committee, Clinical Center, Michigan State University
1979 - 1980 Search committee for Department Chairperson, Pediatrics and Human Development, Michigan State University
1979 - 1981 Alternate Member for William B. Weil, Jr., M.D., on college Planning Committee, College of Human Medicine, Michigan State University

Departmental Committees

2004 - present Hematology/oncology search committee
1994 - Present Executive Committee, Dept. of Pediatrics and Human Development
1994 - Present Division Chief, Peds Hematology/Oncology
1994 - 2002 Management Committee.
2004- present Reappointment Promotion and Tenure committee
2002- Present Grievance Committee
1998 - 2001 Reappointment, Promotion & Tenure Committee
1999 -2000 Neonatology search committee
1997 - 1998 Chair search committee, general pediatrics.
1993 - 1996 Reappointment, Promotion & Tenure Committee
1994 - 1995 Pediatric Residency Task Force Committee, Department of Pediatrics/Human Development
1990 - 1993 Pediatrics/Human Development, Executive Committee
1990 - 1991 Associate Director, Pediatrics/Human Development, Clinical Sub-Specialty Services
1990 - 1991 Pediatrics/Human Development, Residency Advisory Board
1991 - 1992 MSU/E.W. Sparrow Hospital, Pediatric Strategy Committee
1988 - 1991 Reappointment, Promotion & Tenure Committee
1985 - 1989 Pediatric Training Committee (Residency Training)
1984 - 1985 Search committee for Pediatric Residency Director, Michigan State University
1982 - 1983 Pediatric Training Committee, Pediatrics and Human Development, Michigan State University
1979 - 1981 Executive Committee, Pediatrics and Human Development, Michigan State University
1979 - 1985 Reappointment, Promotion and Tenure Committee, Pediatrics and Human Development, Michigan State University

Hospital Committees

2001- Transfusion Committee Sparrow Hospital
1995 - 1996 Pediatric Planning Committee for Pediatric outpatient clinics
1992 - 1995 Executive Committee, Department of Pediatrics, Sparrow Hospital
1992 - 1993 Associate Chair, Department of Pediatrics, Sparrow Hospital
1992 - 1993 Board Member, Action & Advisory Committee, Sparrow Hospital
1991 - 1992 Committee for Helping Children through Bereavement - Ele's Place
1986 - 1989 Oncology Center Committee, E.W. Sparrow Hospital
1982 - Present Tumor Board, E.W. Sparrow Hospital, Lansing, Michigan
1978 - Present Ingham Medical Center, Pediatric Department Committees, Lansing, Michigan
1977 - 1978 Transfusion Committee, St. Lawrence Hospital, Lansing, Michigan

National/Regional Committees

2004 - Present Co chair National Prevention Program, National Hemophilia Foundation
2004 - Present Planning Committee, annual meeting National Hemophilia Foundation
2003- Present Blood Safety Working Group, National Hemophilia Foundation
2003 - Present Thrombosis committee, Hemophilia Research Society (alternate member)
2003 - Present Planning committee and moderator, meeting of the Hemophilia Research Society.
2002 - Present Planning committee American Society of Pediatric Hematology Oncology (ASPHO)
2002 - 2003 Planning Committee, 2003 Annual meeting of the National Hemophilia Foundation
1999 - Present Medical & Scientific Advisory Committee, National Hemophilia Foundation, Region V East representative
2002 Data Committee, Hemophilia Foundation of Michigan
2001- Present Chair Neonatal Task force, National Hemophilia Foundation.
2001- Present Elected to the Universal Data Collection (UDC), working group committee, Center for Disease Control (CDC), Atlanta.
2000 - Present Adolescent and Young Adult Task Force, Children's Oncology Group
2002 - 2003 Michigan Hospice and Palliative Care Committee. Pediatric Work Group
1999 - 2002 Principal investigator Children's Oncology Group
1999 - Present End of Life Task Force, Children's Oncology Group
1999 - 2000 Education and Information Committee, National Hemophilia Foundation
1998- 1999 Nominating Committee, Hemophilia Research Society.
1993- 1995 Medical & Scientific Advisory Committee, National Hemophilia Foundation, Region 10 Representative
1996 - Present Blood club of Michigan
1996 - Present Member Clinical Pathways Committee. Hemophilia Foundation of Michigan
1994 - 1995 American Association of Blood Banks, Transfusion Practices committee (liaison member of the National Hemophilia Foundation)
1992 - 1995 Chair, Medical Advisory Board, Hemophilia Foundation of Michigan>
1994 -2000 Medical Director, Special Days Camp for children with cancer
1988 - Present Michigan Department of Public Health, Pediatric Subspecialty Advisory Board
1988 - 1990 Ethics Committee of Children's Cancer Study Group

Pharmaceutical Advisory boards/ Consultant:

  1. Baxter Corporation North American Clinician Advisory board. 2003
  2. Aventis Behring Physician Advisory board 2002
  3. NovoNordisk Physician Advisory Board 2002, 2003
  4. Wyeth Physician Advisory board 2002

Speakers Bureau

Intramed Continuing Education Group.
FCG institute for education
Health Answers Inc.
Aventis Behring Speakers bureau.
Wyeth Speakers Bureau

Clinical Service:

1977 - Present Director, Pediatric Hematology/Oncology Service, MSU
1977 - Present Director, Pediatric Hemophilia Comprehensive Care Clinic, MSU
1994 - Present Pediatric Hematology/Oncology Outreach Clinic at Marquette General Hospital, Marquette, Michigan
1997 Hemophilia Clinic at Saginaw, Michigan
1996-1997 Gaucher's Disease Treatment Center (with Dr. Wilson)
1996 Cristo Rey Clinic Volunteer (Pediatrician for indigent population)
1992-1993 Pediatric Hematology/Oncology Outreach Clinic at the Burn's Clinic, Petoskey, Michigan
1988 - 1998 Sickle Cell Foundation, designated physician for the Lansing area
1982 - 1999 Regional investigator for Children's Cancer Study Group

Reviewer

1999 - Present Haemophilia
1998 - Present Reviewer for Journal of Pediatric Hematology Oncology
2000 - Present Reviewer American Journal of Hematology
1996 Abstract reviewer for National Hemophilia Foundation National meeting, San Diego, California.
1995 Editorial review AABB tech manual.
1987-89 Grant Reviewer for Children's Leukemia Foundation 1987, 1988, 1989, 1990
1980 & 1989 Basic Research Science Grant BRSG
1992-94 Grant Reviewer for Hemophilia Foundation of Michigan
1994 American Cancer Society Institutional Research Grant.

Teaching Experiences:

2005 - present Longitudinal Patient Care Experience.
2004-present Coagulation course for pediatric resident (a series of 4 lectures)
2003 -present Lecture (2.5 hour) on coagulation. Developed course pack, slide deck on coagulation that included viewing animations on the web
Yearly Grand rounds at Flint, Saginaw, Lansing MI
Yearly Teach Adult hem/oncology fellows and residents as well as students and family practice residents from Escanaba and Marquette MI
Yearly Teach medical students at the pediatric Hem/oncology clinic in Marquette MI.
2002 - Present Mentor program for Year I students, clerkship rotation of 3rd and 4th year students. Nurse practitioner teaching
2001- Present Problem based learning, Clinical Skills and clerkship student teaching
2000 - Present Mentor program, MSU CHM, pediatric clerkship, 4th year hem/onc rotation.
1998-Present Pediatric Clerkship Student Rotation and Marquette General Hospital, pediatric hematology/oncology clinics (students from UP)
1998-1999 Mentor program, MSU CHM, pediatric clerkship, 4th year hem/onc rotation.
1995-1997 Mentor program, MSU CHM, pediatric clerkship, 4th year hem/onc rotation.
1994 -1995 Hematology/Neoplasia Domain Teaching, Doctor-Patient Relationships
1993 -1994 Curriculum Development Group for Hematology Neoplasia Domain
1991-1993 Mentor Program (HM 581), Michigan State University
1989-1997 Newborn Experience, Young Child, and Adolescent Experience.
1988-Present Focal Problems and Newborn Experience
1986-1988 Focal Problems and Adolescent Experience
1986 - 1988 Focal Problems. Medical Ethics
1977 - Present Focal Problems for medical students (HM 510).
1977 - Present Clinical Science and Focused Clinical Appraisal, Michigan State University
1977 - Present Pediatric Clerkships for third and fourth year medical students.
1977 - Present Annual presentations to MSU Clerkship students at, Flint, and Saginaw campuses (till 1990 also included Grand Rapids and Kalamazoo campuses).
1977 - Present Active participant in Pediatric Subspecialty Rounds (weekly).
1978 - 1980 Osteopathic medicine course (OST 551) (Blood groups and blood transfusion).
1977 - 1980 In-service training for nurses at Ingham Medical Center and E.W. Sparrow Hospital (childhood leukemia, blood coagulation and transfusion therapy)
1978 - 1979 Pediatric Transfusion Therapy. Medical Technology Students, Michigan State University
1978 - 1979 Granulocyte Transfusion Therapy, Medical Technologists and Volunteers at Lansing Red Cross
1978 - 1979 Medical Students (III, IV, and final year) and pediatric residents of Osmania University. Indian Institute of Medical Science
1974 - 1975 Medical Students (III and IV year) and pediatric residents, Wayne State University. (Laboratory Hematology)

Animations/ Educational Brochure/ videos/ TV appearances

  1. Animations on von Willebrand Disease for the National Hemophilia Foundation on the web at www.hemophilia.org under Project Red Flag.
  2. Animations on cell based coagulation. Featured on www.hemostasiscme.org 2004
  3. Animations on Dept. web site on "How does Blood Clot?, von Willebrand Disease, Cell based coagulation" on the web at: www.msu.edu/user/phd
  4. TV appearance for MSU health team 2004-2005
  5. TV appearance for "Emerging Pathogens" Baxter Bioscience. 2004. Shown at the World Federation of Hemophilia meetings.
  6. Web CME ASH 2003- Perspectives on control of hemostasis in patients with excessive bleeding. http://www.hemostasiscme.org/. Health Answers Education, FCG institute for continuing education, Philadelphia Pennsylvania.
  7. Evolution of hemophilia care. Panel member for developing CME slide series. A total of 2 slide decks. Intra-Med Educational Group Chicago, 2003.
  8. Hemostasis CME Satellite series Web broadcast for use of recombinant factor VIIa in uncontrolled hemorrhage. Chicago July 2003. The broadcast will be in Oct. 2003. Health Answers Education, FCG institute for continuing education, Philadelphia Pennsylvania.
  9. Panel member for development of CME slides. Set of 3 slide decks; core, medical and surgical regarding mechanism of action and the use of recombinant factor VIIa. Chicago Ill. 2003
  10. Course lecturer on coagulation domain. A 2hr 45 min lecture for HM539. Developed presentation and exam questions.2003
  11. "How does blood clot? Bleeding and clotting disorders: hemophilia, von Willebrand Disease and thombophilias". A computerized animation using Flash technology. Kulkarni R, Reddy U, Evatt B. 2002.
  12. Melvin JR, Horowitz RN, MacDonald D, Kulkarni R, Gannaway J. A Quality and cost effective approach for evaluating patients with possible inherited thrombophilia. Educational Brochure and CD-ROM. Sept. 2002.
  13. Shapiro J, Fung E, Kulkarni R. Education Brochure entitled "Movin' Up" Adult Healthcare. Publication intended for patients with hemophilia transferring from pediatric to adult healthcare and available through the National Hemophilia Foundation at 1-800-42-HANDI. Brochure made possible by an educational grant from Aventis Behring. 2000.
  14. Worked with Dr. Robert Janco, Vanderbilt University, on revising and updating the "STANDARDS AND CRITERIA FOR THE CARE OF PERSONS WITH CONGENITAL BLEEDING DISORDERS". Document published by the National Hemophilia Foundation MASAC in 2001, 2002.
  15. Educational brochure on protein C and S deficiency for the MSU Comprehensive Center for bleeding and clotting disorders.2002
  16. Recommendations for pregnancies at risk for Hemophilia A or B and von Willebrand Disease. 1998-2004
  17. "My Friend has Leukemia." Educational videotape. American Cancer Society.
  18. Participant in "The Dying Child- how to tell a child". Human Development course video. E. Seagull.

Grants/studies:

  1. ------- pediatric study 2005.
  2. -------- adult study 2005
  3. Hemophilia and Thrombosis Society registry 2005.
  4. HIV/Hepatitis study. Regional PI.
  5. CDC Hemostasis and Thrombosis registry funded through CDC grant. 2004-2005.
  6. ATPM application Women and Bleeding Disorders. 2004-2005
  7. Hemophilia Comprehensive Care Grant: Maternal Child Health Bureau (MCHB)( Center for Disease Control, Cascade grant for hemophilia (Service Grant 2004-05)..
  8. Women with bleeding disorder: a pilot study. CDC grant. PI. 2002-2003.
  9. Integration of Thrombotic Disorders into Hemophilia Comprehensive Treatment Centers: Michigan Collaborative Prevention Pilot. CDC grant awarded (collaboration between MSU, U of M and WSU) 2002. CO-PI
  10. ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  11. ------------------------------------------------------------------------------------------------------------------------------------------------------------
  12. ------------------------------------------------------------
  13. ------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  14. Advate Surgical study.
  15. ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  16. ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  17. Hemophilia Comprehensive Care Grant: Maternal Child Health Bureau (MCHB), Center for Disease Control ($110,000), Cascade grant for hemophilia. (Service Grant 2003-04)
  18. PI Childrens Oncology Group 1980- 2001 (Service Grant)
  19. -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  20. ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  21. Academic Achievement of Hemophiliacs 1998 - 2000.
  22. A study of ADHD in Hemophiliacs. MSU, Wayne State University and University of Michigan 1999. Cascade grant with Wayne State University and University of Michigan for study of ADHD in Hemophiliacs, 1999-2000.
  23. Treatment of children with Diamond Blackfan Anemia with high dose methylprednisolone- participant.
  24. National Childhood Cancer Foundation, Children's Cancer Study Group/Children's Oncology Group grants. 1997, 1998, 1999, 2000, 2001.
  25. Cancer Center at Michigan State University, grant for support of pediatric oncology program, 1999.
  26. Randomized trial of interferon and interferon with ribavirin for treatment of hepatitis C in hemophiliacs. Co-PI. 1997.
  27. Obtained grant from Alpha Therapeutics for questionnaire for the study of neonatal intracranial hemorrhage 1996-97.
  28. Cascade grant: Hemophilia Foundation of Michigan to establish clinic in Saginaw, Michigan, 1997.
  29. Children's Leukemia Foundation 1995. Parental caregivers of children with cancer. Co-investigator
  30. Cancer Center at MSU - Cancer Center Planning Grant (NCI) 20 % time. Account 61-1158. 1996.
  31. All-University Research Initiation Grant for 1994-1995.
  32. The Induction of Fetal Hemoglobin (HbF) Production in patients with Sickle Cell Disease. Co-Investigator.
  33. Hemophilia Comprehensive Care Grant Co-PI , Maternal Child Health Bureau (MCHB) Co-PI Center for Disease Control - Co-PI, Cascade grant for hemophilia Co PI.
  34. -----------------------------------------------------------------------------------------------------------------------------------------------------------------------
  35. Alpha-nine SD Brand of Coagulation F-IX (Human) affinity purified organic solvent detergent treated; an open label study of viral safety in previously untreated individuals with hemophilia.
  36. Project 175 - Randomized Double-Blinded Phase I-III Trial of Monotherapy vs Combination with Nucleoside Analogs in HIV Infected Persons with CD4 Cells more than or equal to 200 and less than or equal to 500. 1994. Co-PI
  37. Orion Medical Sciences Institute, "Children's Cancer Study Group Chairman's Grant," awarded 1992 & 1993, 1994, 1995, 1996, 1997, 1998.
  38. BRSG grant (PI), "Granulocyte Transfusion in Septic Newborn Puppies," 1978, awarded.
  39. Children's Leukemia Foundation Grant, Co-PI with Dr. C.W. Smith, 1979, awarded.
  40. Cystic Fibrosis Foundation (PI), "Leukocyte Function in Cystic Fibrosis," 1979, awarded.
  41. BRSG grant (PI), "Free Erythrocyte Protoporphyrin in Patient on Chloromycetin," 1980, awarded.
  42. Hemophilia Foundation of Michigan (PI), "A Comprehensive Study of Antibody Status in Patients with Hemophilia," 1989-91.
  43. BRSG grant (PI), "Protein Kinase C in the Resistance of Human Tumor Cells to Anticancer Drugs," 1990, awarded.

Grant submitted:

2005 Jan. ZLB Behring Foundation for Research and Advancement of patient health. "A survey of menorrhagia and bleeding disorders in a female school population and its impact on school activities and attendance". Roshni Kulkarni, MD; Anjali Pawar, MD; Renuka Gera, MD; Ajovi Scott-Emuakpor, MD; and Kathy Bosma, RN. $-------------

Participation in Clinical trials/task force:

  1. Invited participant: National Data Registry for hemophilia and bleeding disorder. Dallas 2004 and Atlanta 2005
  2. As a member of the CDC's Universal Data Collection Working Group Committee, developed forms for babies ages 0-2years with hemophilia. The form is being piloted nationally.
  3. Neonatal task force of the National hemophilia foundation. Developed a white paper.
  4. Childrens Oncology Group Trials.
  5. Immunologic and genetic parameters associated with inhibitor development in previously untreated patients with severe hemophilia and on Kogenate?. Regional investigator 1995 -96.
  6. A randomized prospective study for the prevention of joint disease in children with Factor VIII deficiency, Opened April 1996.
  7. Children's Cancer Study Group, placement of children with cancer on therapeutic clinical trials.
  8. Recombinant Factor VIII for the Treatment of Previously Untreated patients with Hemophilia A - Safety, Efficacy and Development of Inhibitors. J.M. Lusher, S. Arkin, C.F. Abildgaard, R.S. Schwartz and the Kogenate Previously Untreated Patient Study Group. NEJM 328:453, 1993.
  9. A Multicenter Study of Recombinate Factor VIII (Recombinate): Safety, Efficacy and Inhibitor Risk in Previously Untreated Patients with Hemophilia A. G.L. Bray, E.D. Gomperts, et al., and the Recombinant Study Group. Blood 83(9): 2428-2435, 1994.
  10. Induction of Immune Tolerance in Infants and Children with Hemophilia A and High Responding Inhibitors. A Prospective Study of the Short Term Cost and Effectiveness. Regional RI.
  11. The Psychological Impact of HIV Positivity on the Hemophiliac Child and his Family. Co-PI.

Public and Community Service Presentations:

  1. "Childhood Leukemias: Impact on the Family." Lansing Community College, Lansing, Michigan. Death and Dying Course. Professor, Ray Riskey. 1979.
  2. "Childhood Leukemias." Children's Leukemia Foundation, Lansing Chapter, Lansing, Michigan, May 7, 1979.
  3. "Childhood Leukemia with Reference to a Patient: Susan Guild." Interview by CBS-TV. 1980.
  4. "Childhood Cancers." American Cancer Society, Mason, Michigan.
  5. "Childhood Leukemias." WKAR Radio, Michigan State University, East Lansing, Michigan. September, 1980.
  6. "Childhood Leukemias." American Cancer Society, E.W. Sparrow Hospital, Lansing, Michigan. October, 1981.
  7. "Childhood Leukemia" Interviewed by P.M. Magazine (Syndicated T.V.)
  8. "Bleeding Problems in the Newborn." American Medical Technologists and American Society for Medical Technology Regional Meeting. 1982.
  9. "The Use of Relaxation and Imagery in Children with Leukemia: An Easier Way." Annual Meeting of the Children's Leukemia Foundation, Michigan Division, Kalamazoo, Michigan, June, 1984.
  10. "Neonatal Bleeding Disorders." Region IV of the American Society for Medical Technology. September 27-29, 1984.
  11. "Terminal Illness in Children." Interview by WJIM-TV, Lansing, Michigan, February, 1987.
  12. Presentation at the first Annual Career Night for students who participate in the Mathematics Science Technology at Michigan State University (MST at MSU), July 26, 1996.
  13. "Where and what treatments are available for childhood cancer". Column on House Calls, Lansing State Journal. May 1, 1995.
  14. Expert Panel for Children's Miracle Network. 1993, 1994,1995.
  15. Presentation to Michigan Association of Physicians From India (MAPI), Lansing chapter regarding corporate sponsorship of Special Days Camp for children with Cancer. Obtained $------ for camp activities, 1996.
  16. Math, Science and Technology in Medicine: Presentation at the second Annual Career Night for students who participate in the Mathematics Science Technology at Michigan State University (MST at MSU), July 1997.
  17. The Adolescent Gap in Cancer. Lansing State Journal, Ingham County Medical Society supplement. 1997.
  18. Participant speaker at the Mid-Michigan's third National Cancer Survivors Day Event. June 1997.
  19. Springfest meeting of Hemophilia Foundation of Michigan, Dearborn MI. May 1997. Factor VIII inhibitors, diagnosis and treatment. (invited speaker).
  20. Springfest meeting of the Hemophilia Foundation of Michigan. Dearborn MI. Coagulation 101. R. Kulkarni. May 30, 1998.
  21. Keynote speaker, 1999 annual meeting American Red Cross Great Lakes Blood Services Region. Talk entitled "Blood: the gift of life. Kellogg Center. East Lansing June 22, 1999.
  22. Sparrow Hospital Outreach Program, Michigan Athletic Club. "Sickle Cell Anemia", February 4, 2000.
  23. Springfest meeting of the Hemophilia Foundation of Michigan. Dearborn MI. ADHD and Hemophilia. Troy MI. R. Kulkarni. May 5, 2001.
  24. Cited in HemAware, June 2001, pages 12-19.
  25. Shapiro J; Fung E; Kulkarni R. Education Brochure entitled "Movin' Up" Adult Healthcare. Publication intended for patients with hemophilia transferring from pediatric to adult healthcare. Available through the National Hemophilia Foundation at 1-800-42-HANDI. Brochure made possible by an educational grant from Aventis Behring. 2000.
  26. Inhibitors in hemophilia. Hemophilia Federation of America. Cleveland. April 12, 2002
  27. Gene therapy for hemophilia. Region I and Region III meeting. New York. April 28, 2002.
  28. Clinical Research: a Bond between Community Hospitals and University. Invited presentation to representatives of Pfizer pharmaceutical at the request of the Office of the Vice President for Research, Michigan State University 2003.
  29. MASAC update. Michigan HTC meeting. May 13, 2003. Lansing MI.
  30. Currently available products, treatment, inhibitors and pros and cons of ports. Invited presentation. Region I annual Hemophilia meeting. Sept. 6th 2003
  31. Coagulation 101. National Hemophilia Foundation 55th annual meeting, Salt Lake City, Utah Nov. 2003.
    32. W
  32. omen and bleeding disorder. Women's' Expo. Lansing MI. April 24. 2004
  33. Women and Bleeding disorders. Presented to patients with bleeding disorders. May 6th 2004. Lansing MI.
  34. Transition issues in bleeding disorder patients. Family issues for all generations. Seattle WA. May 8th 2004. NHF on the Road. Unity across generations.
  35. The clotting cascade: an interactive look. Recombinant therapy workshop for hemophilia nurses. Chicago Ill. Aug 21, 2004.
  36. National Alliance of Thrombosis and Thrombophilia meeting. Blood Clots (thrombosis): Overview Education and Discussion Seminar on Blood Clots Detroit, Michigan September 18, 2004.
  37. NHF 2004 Nov 5th "Everything you wanted to know about bleeding". NHF annual meeting, Dallas Texas.

Presentation to the Medical Community:

  1. Physiology of Coagulation. Coagulation Symposium, Ingham Medical Center, Lansing, Michigan. October 28, 1977.
  2. Granulocyte Transfusion. Blood Bank Staff, University of Michigan. 1977.
  3. Hematology/Oncology in Third World Countries. University of Minnesota. 1977.
  4. Acute Leukemia in Children. Michigan Chapter of American Academy of Pediatrics, Boyne Mountain, Michigan. 1978.
  5. Anemia in Childhood. Family Practice Seminar. E.W. Sparrow Hospital, Lansing, Michigan. August 30, 1978.
  6. Cancer -- Its Psycho Social Economic Impact. St. Lawrence Hospital, Lansing, Michigan. April 25, 1979.
  7. Bleeding Problems as They Present in the Emergency Room. for E.R. Physicians at Ingham Medical Center, Lansing, Michigan. October 19, 1979.
  8. Neuroblastoma. Surgical Grand Rounds, Ingham Medical Center, Lansing, Michigan. December, 1980.
  9. Dropping Platelets in the Newborn. Neonatology and Perinatology Conference, E.W. Sparrow Hospital, Lansing, Michigan, November, 1980.
  10. Cancer in the Pediatric Age Group -- Brain Tumors, Leukemia, etc. Presented at a conference on Current Concepts in Cancer and Oncology. Flint, Michigan. May, 1981.
  11. Cancer in the Young. Presented at, Cancer: Its Impact on You. E.W. Sparrow Hospital. May, 1981.
  12. Support for Families. Panel Discussion, Second Annual Leukemia Symposium of the Children's Leukemia Foundation of Michigan, Michigan State University, East Lansing, Michigan. July 11, 1981.
  13. Assessment on Immune Thrombocytopenic Purpura. Presented at a conference on Blood Coagulation: Clinical and Laboratory Aspects. Michigan State University. September, 1983.
  14. Hypnosis, Imagery, and Relaxation in the Practice of Pediatrics. Noll, R.B.; Kulkarni, R.; Solomon, R. Presentation at Pediatric Grand Rounds, Detroit Children's Hospital, Detroit, Michigan. October, 1984.
  15. Long-Term Follow-Up of Language and Cognitive Development of Three Brothers with Mannosidosis. Noll, R.B., Kulkarni, R., Netzloff, M.L. Paper presented at the Annual Meeting of the International Neuropsychological Society, San Diego, California. February, 1985.
  16. Ethical Dilemmas in Pediatric Oncology. Noll, R.B.; Kulkarni, R. Presentation at the Department of Psychology, Michigan State University ethics seminar, Lansing, Michigan. May, 1986.
  17. Integration of Mental Health Services in the Pediatric Oncology Service: Clinical and Research Opportunities. Noll, R.B., Kulkarni, R. Presentation at the bi-annual meeting for the Children's Cancer Study Group, Atlanta, Georgia. April, 1986.
  18. Overview of the Disease Process: Acute Childhood Leukemia. Kulkarni, R. Course presented to Michigan Pharmacists Association/Michigan Society of Hospital Pharmacists, Interim Meeting. Dearborn, Michigan. March 6-8, 1987.
  19. Indications for Infusion of Blood Components: Changes in the 80's. Swisher, S.N.; Schwartz, K.; Penner, J.; Kulkarni, R.; Shafer, A.W. course presented to Michigan State Medical Society, 1987 Annual Scientific Meeting. Dearborn, Michigan. November, 1987.
  20. Presentation to the United Way regarding importance of research in Leukemia. November, 1987 and 1988.
  21. Cancer in Children: The Impact on the Child and the Family from Multiple Perspectives. Noll, R.B., Kulkarni, R., Netzloff, M.L. Presented in San Diego, California, 1988.
  22. Adriamycin Efflux of MCF-7 Resistant and Sensitive Cell Lines. Presentation to Plant Biology Laboratory, MSU, October 1990.
  23. Effect of Verapamil on Adriamycin Efflux of MCF-7 Resistant and Sensitive Cell Lines. Presented at the Oncology Seminar, Department of Medicine, MSU, November 1990.
  24. Decreased Efflux of Adriamycin by Verapamil in Adriamycin Resistant MCF- Human Breast Tumor Cells: A Laser Cytometric Analysis. Kulkarni, R., Madhukar, B.V., Chang, C.C., Trosko, J.E., Dimitrov, N., Jou, Y.S., Jiwa, A., Charmella, L. American Cancer Society 1991 Research Conference, Detroit, MI, September 20, 1991.
  25. Increased Retention of Adriamycin by a Protein Kinase C Inhibitor, Calphostin C in Resistant MCF-7 Human Breast Tumor Cells. R. Kulkarni, B.V. Madhukar, H. Rupp, C. Chang, J.E. Trosko, L. Charmella, N. Dimitrov. The Ohio Valley-Lake Erie Association of Cancer Centers (OLACC) Meeting, September 11, 1992.
  26. Drug Resistance in Cancer Cells. Presented to the Michigan Cancer Consortium, October 1992.
  27. DIC and Gram Negative Sepsis. Medicine Grand Rounds, Hurley Hospital, Flint, Michigan, 1993.
  28. Septic Shock in Children. Presentation to ER Physicians, E.W. Sparrow Hospital, Lansing, Michigan, 1993.
  29. Brain Tumors in Children. Neurosurgery Rounds, E.W. Sparrow Hospital, Lansing, Michigan.1994
  30. The Science and Politics of Women's Health in America. Wayne State University School of Medicine, The Westin Hotel, Detroit, Michigan, May 12, 1993.
  31. Hemophilia: Past, Present and Future. Kulkarni, R. Invited Presentation for the Michigan Academy of Pediatric Dentistry Winter Meeting, Hotel Baronette, Novi, Michigan, March 5, 1994.
  32. Current Issues in Hemophilia. R. Kulkarni. Presentation at the Region V Meeting and Provider Retreat, National Hemophilia Foundation, South Bend, Indiana, September 1994
  33. Career Development of Women in Academic Medicine. Presentation to the Primary Care Faculty Development Fellows, Michigan State University, June 7, 1994.
  34. Cranial Hemorrhages in neonatal hemophilia. Region V-East Hemophilia Treatment Center Meeting and provider retreat, Ohio. Sept. 13, 1995.
  35. New Strategies in the Diagnosis and treatment of Acute Childhood Leukemia; Presented at the Adult Hematology/ Oncology Conference. MSU. Sept. 1995.
  36. Cranial Hemorrhages in neonatal hemophilia. Marquette General Hospital Physician and nursing conference. Nov.1995.
  37. Cranial Hemorrhages in Neonatal Hemophilia. Medical and Scientific Advisory Committee (MASAC), National Hemophilia Foundation, Philadelphia Oct.14, 1995.
  38. Acute lymphoblastic leukemias in children. R. Kulkarni. presentation to the epidemiology research group. 1996.
  39. The Adolescent Gap and issues in Pediatric cancer. Cancer Committee. Sparrow Hospital, Sept. 1996.
  40. Meeting the Challenges of Pediatric Hematology and Oncology. R. Kulkarni. Fifth Annual Outreach Conference. Sparrow Regional Childrens Center. Marriott University Place. East Lansing. Oct. 15, 1996.
  41. Stress management for resident physicians. Sparrow Hospital, Oct. 30, 1997 Panel member. Coordinator Dr. J Brady.
  42. Current practices regarding neonatal intracranial hemorrhage and obstetrical care and mode of delivery of pregnant hemophilia carriers. Medical and Scientific Advisory Committee (MASAC) National Hemophilia Foundation, New Orleans, Nov. 1997.
  43. National Hemophilia Foundation Medical and Scientific Advisory Committee (MASAC): Recommendations regarding neonatal intracranial hemorrhage and deliveries, New Orleans, Nov. 1997.
  44. Quality of life issues for cancer patients and their families. Children's Leukemia Foundation. Detroit Michigan, April 22, 1998.
  45. Inhibitor meeting. Invited participant, Nabi Pharmaceuticals, summer 1998.
  46. Meeting today's needs. Facing tomorrow's challenges. Midwest Bleeding Disorders Conference. September 17-18, 1998. Chicago, IL. Co-chair, physicians discussion group.
  47. Shortages of clotting factors. Invited participant, Centeon Laboratories. Chicago, IL, September 9, 1998.
  48. Acute Lymphoblastic Leukemia in Children. Invited Speaker. Pediatric/Perinatal Update. Marquette, MI. September 25, 1998.
  49. Adolescent and Childhood Leukemias. Department of Internal Medicine, Hematology/ Oncology Division, October 23, 1998.
  50. Acute Lymphoblastic Leukemia in Children and Adolescents. Department of Family Practice, November, 1998.
  51. Intracranial Hemorrhage in Newborn with Hemophilia: Prevention, Recognition, Management and Neonatal Care. Conference on Women with Bleeding Disorders. New York, March 19, 1999 (Invited Speaker).
  52. New Research: Current Hemophilia Research. Presentation. The future of hemophilia care: preparing for the 21st century. 1999 Region V-east meeting. Sept. 1999. Newbury, Ohio.
  53. Intracranial Hemorrhage. Pre-, peri-, Neonatal issues in the management of infants with bleeding disorders. 1999 National Hemophilia Foundation Symposium. Management of the neonate. Nov. 4-6 Dallas, Texas.
  54. Neonatal Hemophilia. Invited speaker. Grand rounds presentation. Medical College of Ohio, Toledo, Ohio. Oct. 11, 2000.
  55. Perinatal issues in hemophilia. Invited speaker. Ob-gyn Grand rounds. Sparrow hospital. Oct. 17, 2000.
  56. Prenatal, perinatal and neonatal issues in hemophilia. Invited speaker. CDC Atlanta. Oct. 23, 2000.
  57. Perinatal issues in newborns with hemophilia. Region 1 meeting. Salem, MA. April 27, 2001.
  58. The Hemophilia Expert Panel meeting on the cost effectiveness of care of hemophilia with inhibitors, July 9, 2001. Hotel Le Meridien Etoile in Paris, 81 Boulevard Gouvion Saint-Cyr, Paris, France.
  59. Neonatal alloimmune thrombocytopenia. Invited speaker. Neonatology conference. Sparrow Hospital. Aug. 28. 2001.
  60. Head trauma in hemophilia; a hematologist approach. Invited speaker. The 53rd Annual meeting. National Hemophilia foundation. Nov. 16th, 2001.
  61. Infectious complications of central venous catheters in hemophilia" Round table on prophylaxis and unsolved problems in prophylaxis. Rome Italy, Saturday April 20, 2002.
  62. Animation of "How does blood Clot and von Willebrand Disease" Regional Hemophilia meeting. Fort Wayne. Indiana. 2002.
  63. Non Hemophilic use of Recombinant FVIIa . Ball State University. Muncie , Indiana, 2002
  64. Animation of "How does blood Clot and von Willebrand Disease" Medical and Scientific Advisory Committee Meeting. National Hemophilia Foundation, Orlando Nov. 2002.
  65. Use of recombinant Factor VIIa in pediatric liver trauma. Case presentation and animation of the physiology of blood clotting. Selected for presentation at the rFVIIa innovators conference. Scottsdale AZ. Dec 2002.
  66. Invited participant High Responder Inhibitor workshop. Dallas Texas. March 18-19, 2003.
  67. From bench to trench and beyond. Annual Research Day. Dept. of Pediatrics and Human Development. May 30, 2003.
  68. Presented for Dr. Warrier. ISTH subcommittee report: Registry on FIX inhibitors and anaphylaxis. Warrier I, M.D. [Presented by Roshni Kulkarni, M.D.] Birmingham UK. July 2003
  69. Advate AHF-PFM clinical program update. Chicago Recombinant Therapy workshop. Aug 2nd. 2003 Chicago Illinois
  70. New Concepts in Hemostasis Management: The Case for New Treatment. Chicago. Web-cast aired in Oct Nov and December 03.
  71. Overview of hemophilia. Grand Rounds. Invited presentation at the Sunrise Childrens Hospital. Las Vegas. Oct 26th 2003
  72. Understanding von Willebrand Disease: Symptoms, Prevalence and Treatment. Southfield MI, Sept. 29th 2003. Presentation to hematology/oncology physicians and nurses from Childrens Hospital of Michigan, Henry Ford and Beaumont hospitals.
  73. Overview of the Hemophilia and Thrombosis Research Society. Presented for Dr. T. Abshire at the National Hemophilia Foundation meeting Salt Lake City Nov 2003.
  74. "The Need for a plasma/albumin -free method" Baxter symposium on: The Latest Advancement in Hemophilia A Therapy: The First and Only Plasma/Albumin-free Recombinant Antihemophilic FVIII: Advate (rAHF-PFM). National Hemophilia Foundation meeting Salt Lake City Nov 2003.
  75. A hematologists approach to treating a patient with massive bleeding. R. Kulkarni. Symposium on Perspectives on the control of Hemostasis. American Society of Hematology. Dec. 5th 2003.
  76. Von Willebrand Disease and other inherited bleeding disorders in patients with menorrhagia. Symposium on Select Bleeding Disorders in Women, Department of Laboratories, Sparrow Hospital. Kellogg Center, March 16, 2004.
  77. Cell based coagulation: the cornerstone to treatment of excessive bleeding episodes. Presented at the symposium entitled "Hemostasis management in trauma" Trauma and Critical Care conference. March 22, 2004, Las Vegas, Nevada.
  78. An Interactive Look at the Coagulation Cascade "American Association of Neuroscience Nurses. Tuesday, April 20, 2004. San Antonio, Texas.
  79. Massive bleeding: A hematologist approach. Grand Rounds presentation to Emergency room, surgical and trauma residents and physicians. Sparrow hospital May 5th 2004.
  80. Manufacturing and Processing of Blood-Related Therapeutics. Eric P. Newman Center, Washington University, St. Louis, Missouri June 5-6, 2004.
  81. Prevalence of heart disease in hemophilia. Invited presentation. National Center for Birth Defects and Developmental Disabilities, Centers for Disease Control. Aug 5th 2004
  82. A hematologist approach to Massive hemorrhage. Invited speaker for grand rounds at Geisinger Hospital, Danville PA. Aug 24, 2004
  83. Keynote Speaker. New advances in the management of bleeding disorders. Von Willebrand Disease and women with bleeding disorders. Pediatric and Perinatal Update 2004. Sept. 16th, 2004. Marquette MI.
  84. Perinatal and Pediatric update. Evolution of Hemophilia care. Marquette General Hospital. Marquette MI. Sept 17, 2004.
  85. Cell based coagulation, an animated approach. Invited speaker, Am Society of Hematology, corporate Friday symposium. Dec 2004.
  86. Adolescents and women with bleeding disorders. Grand Rounds, Sparrow Hospital. Jan 2005
  87. Massive hemorrhage: A hematologists' perspective. Invited presentation. Surgery grand rounds Jan 27th 2005
  88. Women and Bleeding disorders. Presentation to the medical Staff, Railway Hospital, Perambur, Chennai, India Feb 2005.

Publications:

  1. Iyer, R., Ravindranath, Y., Kulkarni, R., Philippart, A., Reed, J.O., Brough, A. J., Zuelzer, W.W.: Bilateral Interstitial Pneumonia in Acute Lymphoblastic Leukemia. Am. J. Hematology 1:225-235, 1976.
  2. Kulkarni, R., Rao, V.K.M., Bopardikar, K.R.: A Study of Leukemia. Indian Pediatrics, Vol. XIV, No. 2, February 1977.
  3. Kulkarni, R., Bailie, M.D., Bernstein, J., Newton, B.: Progression of Nephroblastomatosis to Wilms Tumor. J. Pediatrics, 96:1:178, January 1980.
  4. Kulkarni, R.: Report presented to the Government of India of the "Need for Establishment of a Department of Hematology in Niloufer Hospital.: Hyderabad, India, 1981.
  5. Kulkarni, R., Murray, D.L., Gupta, S., deMendonca, W.C., Leader, I.: Multiple Splenic Aspergillomas in a Patient with Acute Lymphoblastic Leukemia. American Journal of Pediatric Hematology/Oncology, 4(2):141-145, 1982.
  6. Kulkarni, R., Netzloff, M.L., Texiera, C.: Familial Cryptochidism and Testicular Tumors in Non-Twin Brothers. Annals of Clinical and Laboratory Science, 13(4): 327-331, 1983.
  7. Noll, R.B., Kulkarni, R.: Complex Visual Hallucinations and Cyclosporine. Archives of Neurology, 41:329, 1984.
  8. Noll, R.B., Kulkarni, R., Netzloff, M.L.: Follow-Up Language and Cognitive Development in Three Brothers with Mannosidosis. Archives of Neurology, 43:157-159, 1986.
  9. O'Malley, D.P., Cousineau, A.J., Kulkarni, R., Higgins, J.V.: Double Minute Chromosomes: A Bone Marrow Indicator of Neuroblastoma Metastasis and Relapse: Two Case Reports. Cancer, 57(11):2158-2161, 1986.
  10. O'Malley, D.P., Kulkarni, R., Oaks, M.K., Higgins, J.V.: Acute Lymphoblastic Leukemia with a Unique Rearrangement between Chromosomes 4 and 11. Cancer Genetics and Cytogenetics, 31:291-294, 1988.
  11. Kumar, A., Brar, S.S., Murray, D.L., Leader, Il, Gera, R., Kulkarni, R.: Central Venous Catheter Infections in Pediatric Patients--In a Community Hospital. Infection, 16:86-90, 1988.
  12. Noll, R.B., Kulkarni, R.: Cognitive and Motor Development of Infants Coping with Cancer: Longitudinal Observations. Infant Mental Health Journal, 10(4):252-262, 1989.
  13. My Friend has Leukemia. Educational Video Tape for the American Cancer Society.
  14. Noll, R.B., Netzloff, M.L., Kulkarni, R.: Long Term Follow-up on Biochemical and Cognitive Functioning in Patients with Mannosidosis. Archives of Neurology, 46:507-509, 1989.
  15. Moore, J.B., Kulkarni, R., Crutcher, D.C., Bhimani, S.: MRI in Multifocal Eosinophilic Granuloma. Staging Disease and Monitoring Response to Therapy. American Journal of Pediatric Hematology/Oncology, 11(2):174-177 1989.
  16. Noll, R.B., Bukowski, W.M., Rogosch, F.A., LeRoy, S.S., Kulkarni, R.: Social Interactions between Children with Cancer and their Peers: Teacher Ratings. Journal of Pediatric Psychology, 15(1):43-56, 1990.
  17. Noll, R.B., LeRoy, S.S., Bukowski, W.M., Rogosch, F.A., Kulkarni, R.: Peer Relationships and Adjustments of Children with Cancer. Journal of Pediatric Psychology, 16(3):307-326, 1991.
  18. Kumar, A., Gera, R., Kulkarni, R., Hogreffe, W., Kaufman, D.B.: Immunoglobulins in Hemophilia: Correlation Between IgG Subclasses, IgE and HIV Antibody. J. Clin. Lab. Immunol. 31:157-160, 1990.
  19. Kumar, A., Gera, R., Kulkarni, R.: Polyfungal Systemic Infections in Pediatric Oncology Patients.
  20. Maeda, M., Bawle, E.V., Kulkarni, R., Beutler, E., Yoshida, A.: Molecular Abnormalities of a Phosphoglycerate Kinase Variant Generated by Spontaneous Mutation. Blood 79(10):2759-2762, 1992.
  21. Krivit, W.S., Freese, D., Chan, K., Kulkarni, R.: Wolman's Disease: A Review of Treatment with Bone Marrow Transplantation and Consideration for the Future. Bone Marrow Transplantation, Vol. 10, Supp. 1, 1992; 97-101. Proceedings of the Symposium on Bone Marrow Transplantation, Keystone, CO., January 13-26, 1992.
  22. Noll, R.B., Bukowski, W.M., Davies, W.H., Koontz, K., Kulkarni, R.: Adjustment in the Peer System of Adolescents with Cancer: A Two-Year Study. Journal of Pediatric Psychology 18(3):351-364, 1993.
  23. Davies WH, Noll RB, DeStefano L, Bukowski WM, Kulkarni R. Differences in the child-rearing practices of parents of children with cancer and controls: the perspectives of parents and professionals. J Pediatr Psychol. 1991 Jun;16(3):295-306.
  24. Kumar, A., Kulkarni, R., Murray, D.L., Gera, R., Scott-Emuakpor, A.B., Bosma, K., Penner, J.A.: Serologic Markers of Viral Hepatitis A, B, C and D in Patients with Hemophilia. J. Med. Virology 41:205-209, 1993.
  25. Kulkarni R. Just Say Know: Information on Parvovirus, Hepatitis and CMV. Hemophilia Update. Hemophilia Foundation of Michigan. Third/Fourth Quarter, 1994.
  26. Barnes CL, Gera R, Kulkarni R. Impact of childhood cancer on patients: Caregiver reaction assessment. Supportive Care in Cancer, 4(3):241, 1996.
  27. Balkundi DR., Murray DL., Patterson MJ., Gera R., Scott-Emuakpor., Kulkarni R: Penicillin resistant Streptococcus mitis as a cause of septicemia with meningitis in febrile neutropenic children. The American Journal of Pediatric Hematology/Oncology, 19(1): 82-85, 1997.
  28. Thiessen B, Finlay J, Kulkarni R, Rosenblum M. Astroblastoma: Does histology predict biologic behavior? Journal of Neuro-oncology, 40(1):59-65, 1998.
  29. Onyekwere OC, Hoover L, Gera R, Kulkarni R and Scott-Emuakpor AB. Sickle cell disease in children: Update for the primary care provider. Medical Update for Psychiatrists, 3:205-208, 1998.
  30. Gera R and Kulkarni R. Venous Thromboembolism. Indian J Pediatr, 66:163-169, 1999.
  31. Kulkarni R and Gera R. Pediatric Transfusion Therapy: Practical Considerations. Indian J Pediatr, 66:307-317, 1999.
  32. Kulkarni R and Lusher JM. Intracranial and Extracranial Hemorrhages in Newborns with Hemophilia: A Review of the Literature. J Pediatr Hematol Oncol, 21(4):289-295, 1999.
  33. Kulkarni R, Lusher JM, Henry RC and Kallen DJ. Current practices regarding newborn intracranial haemorrhage and obstetrical care and mode of delivery of pregnant haemophilia carriers: a survey of obstetricians, neonatologists and haematologists in the United States, on behalf of the National Hemophilia Foundation's Medical and Scientific Advisory Council. Haemophilia. 5(6):410-415, 1999.
  34. Kulkarni R. Recognize it early: Head bleeds in newborns with hemophilia. HEMAware. National Hemophilia Foundation. October 2000, pp. 44-49.
  35. White GC, Aledort L., Bell W, Britton HA, Davignon GF, Ewenstein B, Ewing NP, Green D, Hanna WT, Hoots WK, Joist JH, Kessler C, Kulkarni R, Leissinger C, Luban N, Manco-Johnson M, Penner J, Seremetis SV. Treatment of Hemophilia Patients with Factor VIII inhibitors: Proceedings of a Consensus panel. A CME program by Nabi pharmaceuticals May 2001, pages 6-16.
  36. Kulkarni R, Scott-Emuakpor AB, Brody H, Ragni MV, Weil WB, Gera R, Bosma K, Penner JA, and the Center for Ethics and Humanities in the Life Sciences at Michigan State University. Nondisclosure of HIV/HCV in a Co-infected hemophilic male: medical and ethical dilemma. Journal of Pediatric Hematology/Oncology 2001; 23:153-158.
  37. Kulkarni R and Lusher J. Perinatal management of newborns with haemophilia. British Journal of Haematology 112:264-274, 2001.
  38. Kulkarni R. Bleeding in the Newborn. Pediatric Annals 30:548-556, 2001.
  39. Kulkarni R, Aledort LM, Berntorp E, Brackman HH, Brown D, Cohen AR, Ewing NP, Gringeri A, Gruppo R, Hoots K, Leissenger C, Peerlinck K, Poon MC, Wong WY. Therapeutic choices for patients with haemophilia and high titre inhibitors. American Journal of Hematology 67:240-246, 2001.
  40. Robbins D, Kulkarni R, Gera R, Scott-Emuakpor AB, Bosma K, Penner JA. Successful Treatment of High Titer Inhibitors in Mild Hemophilia A with Avoidance of Factor VIII and Immunosuppressive Therapy. American Journal of Hematology 68:184-188, 2001.
  41. Kulkarni R, J. Wolf JS, Padiyar N, Zuckerman L, Gera R, Scott-Emuakpor AB. Severe intrarenal fibrosis, infundibular stenosis, renal cysts and persistent nephrogenic rests, in a patient with Beckwith Wiedemann syndrome 27 years following diffuse nephroblastomatosis (DNB) and Wilms tumor (WT): Natural progression or a consequence of treatment? Accepted by Journal of Pediatric Hematology/Oncology. 2002 Jun-Jul;24(5):389-93.
  42. White paper for research priorities. Neonatal task force. National Hemophilia Foundation.
  43. Olomu N, Kulkarni R, Manco-Johnson M. Treatment of severe pulmonary hemorrhage with activated recombinant factor VII (rFVIIa) in very low birth weight infants: case reports. Journal of Perinatology 2002; 22 (8), 672-674.
  44. Brown SA, Aledort LM, Astermark J, Berntorp E, van den Berg M, Blanchette V, Donfield S, Gringeri A, Hilgartner M, Kulkarni R, Leissinger C, Negrier C, Nuss R, Petterson H, Petrini P, Poulios N, Schramm W. Unresolved issues in prophylaxis. Haemophilia. 2002 Nov;8(6):817-21
  45. Vyas H, Scott-Emuakpor A, Kulkarni R, Gera R. Acute Leukemias in Children. Submitted to the Indian Journal of Pediatrics.
  46. Kulkarni R, Soucie MJ, Evatt B. Renal disease among males with hemophilia. Haemophilia 2003; 9: 703-710.
  47. Soucie JM, Cianfrini C, Robert L. Janco RL, Kulkarni R, Hambleton J, Evatt B, Forsyth A, Geraghty S, Hoots K, Abshire T, Curtis R, Huszti H, Wagner M, White GC, II. Joint range-of-motion limitations among young males with hemophilia: prevalence and risk factors. Blood 103:2467, 2004. (E-pub ahead of print. Blood Nov 03). Blood First Edition Paper, prepublished online November 13, 2003; DOI 10.1182/Blood-2003-05-1457
  48. Bussel JB, Eldor A, Kelton JG, Varon D, Brenner B, Gillis S, Angiolillo A, Kulkarni R, Abshire TC, Kelleher J and the IGIV-C in ITP study group. IGIV-C a novel intravenous immunoglobulin: evaluation of safety, efficacy, mechanisms of action and impact on quality of life. Thrombosis and Hemostasis 91 (4): 771-8, 2004.
  49. Kulkarni R, Daneshmand A, Guertin S, Fath J, Atwal J, Melvin J, LaFrance Successful use of recombinant factor VIIa (rFVIIa) in traumatic liver injuries in children. J Trauma.2004 56 (6): 1348-52.
  50. ---------------------------------------------------------------------------------------------------------------------- --------------------
  51. -------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Published Abstracts (*denotes oral presentation; **denotes poster presentation):

  1. Rapid Diagnosis of Meningitis Using Cytocentrifugation Technique. Kulkarni, R., Leader, I., Murray, D. Society of Pediatric Research, 1982.
  2. *Familial Occurrence of Cryptorchidism and Testicular Tumors in Non-Twin Brothers. Kulkarni, R., Netzloff, M, Texeira, C. Society for Pediatric Research, 1982.
  3. A Canine Neonate Model for the Study of Granulocyte Transfusion in Septicemia. Kulkarni, R., Karna, P., Coffman, P., Bull, R. Society of Pediatric Research, 1982.
  4. Immunological Evaluation of Patients with Hemophilia. Gera, R., Jin, Z., Cleveland, R., Murray, D., Kulkarni, R., Romond, E., Kaufman, D.B.. Society for Pediatric Research, May 1984.
  5. Unique Chromosome Abnormality in a Child with Pre B Cell Leukemia. Cousineau, A.J., Gera, R., Kulkarni, R. Society for Pediatric Research, 1984.
  6. Tryptophan Pyrrolase Activity and Elevated Brain 5-HT in Iron Deficient Rats: A Mechanism for Behavioral Changes. Kulkarni, R., Gera, R., Draznin, M., Parker, L. American Society of Hematology, 1985.
  7. A New Infantile Acute Leukemia with a Unique Chromosomal t(4;11) Rearrangement. O'Malley, D.P., Kulkarni, R., Higgins, J.V. Pediatric Research, April, 1985.
  8. *Role of Gap Junctional Intercellular Communication in the Regulation of Growth and Differentiation of Normal and Malignant Human Epithelial Cells. Trosko, J.E., Chang, C.C., El-Fouly, M.H., Kulkarni, R., Gera, R. Fourth Decennial Review --- Cell and Tissue Culture International Conference, September 22-26, 1986.
  9. *Inhibition of Intercellular communication in Human Carcinoma Cell Lines of Various Origins as Determined by Three Newly Developed Methods. Gera, R., Kulkarni, R., El-Fouly, M.H., Chang, C.C., Trosko, J.E. American Association for Cancer Research, 1987.
  10. A Platelet Aggregation Factor in Plasma from Sickle Cell Disease. Turner, E., Bolenbaugh, J.G., Gera. R., Kulkarni, R. American Society for Hematology. 1987.
  11. Central Venous Catheter Infections in Pediatric Patients in a Community Hospital. Kumar, A., Brar, S.S., Murray, D.L., Leader, I., Gera, R., Kulkarni, R. Society for Pediatric Research, vol. 23, April 1988.
  12. Reinduction Chemotherapy for Children with Acute Lymphoblastic Leukemia in Relapse. Gera, R., Scott-Emuakpor, A., Noll, R.B., Kulkarni, R. American Society of Hematology, 1989.
  13. *Mechanisms of Adriamycin-resistance of human breast cancer cell line, MCF-7. Kulkarni, R., Madhukar, B.V., Jou, Y.S., Jiwa, Y., Chang, C.C., Charmella, L., Trosko, J.E., Dimitrov, N. American Cancer Society, 1991 Cancer Research Conference, Detroit, MI, September 20, 1991.
  14. A comprehensive study of antibody status in patients with hemophilia. Kulkarni, R., Kumar, A, Penner, J.A., Murray, D., Anderson, G, Gera, R., Scott-Emuakpor, A.B. Blood 76(10):426a, 1990.
  15. **Should children with cancer avoid school and crowded places during periods of treatment realted neutropenia? Results of a survey. Gera, R., Kulkarni, R., Scott-Emuakpor, A.B. The American Society of Pediatric Hematology/Oncology, Fourth Annual Meeting Scientific Proceedings, page 26, September 12-14, 1991.
  16. **Antibody Status in Patients with Hemophilia - A Comprehensive Study. Kulkarni, R., Kumar, A., Murray, D., Anderson, G., Gera, R., Scott-Emuakpor, A.B., Bosma, K., Penner, J.A. National Hemophilia Foundation 43rd Annual Meeting, Tampa, October 8-12, 1991.
  17. **Serologic Markers of Viral Hepatitis A, B, C and D in Patients with Hemophilia. Kumar, A., Kulkarni, R., Murray, D.L., Gera, R., Scott-Emuakpor, A.B., Bosma, K., Penner, J.A. National Hemophilia Foundation 43rd Annual Meeting, Tampa, October 8-12, 1991.
  18. **Successful Treatment of Thrombocytopenia with Intravenous Immunoglobulin (IV IgG) During Induction (I) and Consolidation (C) Phase of all in a Patient (PT) with Underlying ITP. Gera, R., Kulkarni, R., Scott-Emuakpor, A. The American Society of Pediatric Hematology/Oncology, Fifth Annual Meeting Scientific Proceedings, page 33, September 24-26, 1992.
  19. *Increased Retention of Adriamycin by a Protein Kinase C Inhibitor, Calphostin C in Resistant MCF-7 Human breast Tumor Cells. R. Kulkarni, B.V. Madhukar, H. Rupp, C. Chang, J.E. Trosko, L. Charmella, N. Dimitrov. Proceedings of the American Association of Cancer Research, volume 33, page 438, March 1992.
  20. **HIV Infection Associated with Urinary Tract Infection (UTI) in Hemophiliacs. Scott-Emuakpor, A.B., Gera, R., Kulkarni, R., Kumar, A., and Bosma, K. Scientific Proceedings of the American Society of Pediatric Hematology/Oncology, page 32, September 1992.
  21. **Thrombocytosis in the Newborns. Gera, R., Tam Su, A., Kulkarni, R., Lorenz, J. Scientific Proceedings of the American Society of Pediatric Hematology/Oncology, page 28, September 1993.
  22. **Vaccination Responses of Patients with Hemophilia. Kulkarni, R., Gera, R., Kumar, A., Murray, D., Scott-Emuakpor, A.B., Anderson, G., Downs, F.P., Bosma, K., and Penner, J.A. Scientific Proceedings of the American Society of Pediatric Hematology/Oncology, page 28, September 1993.
  23. **A Time and Cost Analysis of Patient Provided versus Hospital Provided Clotting Factor Concentrates for Outpatient Treatment of Hemophilia in a Community Hospital. M. Kalyanaraman, R. Kulkarni, R. Gera, A.B. Scott-Emuakpor, K.Bosma, S. Jensen, J.A. Penner. National Hemophilia Foundation Annual Meeting, October 1994.
  24. **Totally Implantable Subcutaneous Ports for Long Term Venous Access in patients with Various Bleeding Disorders. R. Gera, R. Kulkarni, A.B. Scott-Emuakpor, K. Bosma, J.A. Penner. National Hemophilia Foundation Annual Meeting, October 1994. Published as a selected abstract in Transfusion 35(5):440, 1995.
  25. Viral Safety of an Affinity Purified Coagulation Factor IX Concentrate (Alphanine?,SD). D Becton, C Manno, D Green, G Gilchrist, R Kulkarni, J Priest, C Sexauer, W Schlueter and F Norton. Blood, 1994
  26. **Chronic bone marrow failure syndrome with Myelodysplasia in two adopted Korean children. R. Gera, R. Kulkarni and A.B Scott-Emuakpor. ASPHO. 1995
  27. **Penicillin resistant streptococcus mitis (Sm) meningitis in febrile neutropenic children (FNC). R Gera, D Balkundi, MJ Patterson, AB Scott-Emaukapor, DL Murray, R Kulkarni. ASPHO. 1995.
  28. Viral safety of an affinity-purified coagulation Factor IX concentrate (Alpha Nine? SD). D Becton, C Manno, M Heisel, D Beardsley, D Green, G Gilchrist, R Kulkarni, T Loew, J Priest, C Sexauer, W Schlueter, R Nuss and F Norton. XXII International Congress of the World Federation of Hemophilia, Dublin , Ireland June 1996.
  29. **Impact of childhood cancer on parents: Caregiver reaction assessment. C.L. Barnes, R. Gera and R. Kulkarni. Poster presentation at the MASCC Eighth International Symposium on supportive care in cancer. Toronto, Canada. June 1996.
  30. **Microcytic Hypochromic Anemia (MHA) and Lymphoblastic Lymphoma/Acute Lymphoblastic Leukemia. R. Gera, R. Kulkarni and A.B. Scott-Emuakpor. The American Society of Pediatric Hematology/Oncology. Chicago, Sept.10-12, 1996.
  31. **Childhood Cancer Care: Feelings of Depression in parents. C.L. Barnes R. Gera, R. Kulkarni and A.B. Scott-Emuakpor. The American Society of Pediatric Hematology/Oncology. Chicago, Sept.10-12, 1996.
  32. **Cancer Care in Children: Parents' Perception of Financial Burdens. R. Gera, C.L. Barnes , R. Kulkarni and A.B. Scott-Emuakpor. The American Society of Pediatric Hematology/Oncology. Chicago, Sept.10-12, 1996.
  33. **Transient magnetic resonance imaging (MRI) changes in central nervous system (CNS) following seizures in patients with acute lymphoblastic leukemia (ALL): Ischemia or postictal change? R. Gera, R. Kulkarni and A.B. Scott-Emuakpor. The American Society of Pediatric Hematology/Oncology. San Francisco, Sept.1997.
  34. **Neurologic sequelae of intrathecal methotrexate: a case of severe debilitating leukoencephalopathy. R. Gera, R. Noll and R. Kulkarni. The American Society of Pediatric Hematology/Oncology. San Francisco, Sept.1997.
  35. *Neonatal intracranial hemorrhage and obstetrical care and mode of delivery of pregnant hemophilia carriers: A survey of obstetricians, neonatologists and hematologists in the United States. Kulkarni R, Lusher JM, Henry RC and Kallen DJ. XXIII International Congress of the World Federation of Hemophilia. The Netherlands Congress Centre. The Hague. May 18,1998.
  36. **A review of cranial hemorrhages in neonatal hemophilia. Kulkarni R and Lusher JM. XXIII International Congress of the World Federation of Hemophilia. The Netherlands Congress Centre. The Hague. May 18, 1998.
  37. **Long term intranasal desmopressin acetate prophylaxis and avoidance of factor VIII concentrates (FVIIIc) in mild hemophilia a (mha) with high titer inhibitors (HTI). Robbins D*, Kulkarni R, Gera R, Scott-Emuakpor A, Bosma K and Penner JA, Michigan State University, East Lansing, MI, USA. XVIIth Congress of the International Society of Thrombosis and Haemostasis. Washington D.C. Aug 17, 1999.
  38. **Nondisclosure of HV/HCV in a Co-infected hemophilic male: medical and ethical dilemma. Kulkarni R, Scott-Emuakpor AB, Brody H, *Ragni MV, Weil WB, Gera R, Bosma K, Penner, JA, and the Center for Ethics and Humanities in the Life Sciences, Michigan State University, East Lansing, MI, USA and *University of Pittsburgh, PA, USA. 1999 Joint Annual meeting of the International Society of Pediatric Oncology and the American Society of Pediatric Hematology/Oncology. Montreal CA. Sept. 17. 1999
  39. Primary orbital lymphoma in children: A report of two unusual cases. Elliott M, Kulkarni R, Gera R, Scott-Emuakpor AB, Padiyar N, Cavanaugh E, Rice C, Hoover L, Patterson MJ, Michigan State University, East Lansing, MI, USA. J. Pediatr Hematol Oncol 21(4):313, Abstract No. 196, 1999.
  40. **Fatal hyperkalemia during surgery for Burkitt's lymphoma (Bl). Gera R, Scott-Emuakpor AB, Kulkarni R, Greenfeld J, Lelli J, Michigan State University, East Lansing, MI, USA and University of Michigan, Ann Arbor, MI, USA. J Pediatr Hematol Oncol 21(4): 313, Abstract No. 194, 1999.
  41. **ADHD in 6-14 year old hemophilia population pilot study. Merritt D, McGinty L, Palazzolo V, Adkins S, Bosma K, Munn J, Gera R, Kulkarni R, Pipe S, Warrier I. National Hemophilia Foundation 52nd Annual meeting CA 2000.
  42. *ADHD in 6-14 year old hemophilia population pilot study. Merritt D, McGinty L, Palazzolo V, Adkins S, Bosma K, Munn J, Gera R, Kulkarni R, Pipe S, Warrier I. World Federation of Haemophilia, July 2000, Montreal
  43. **Long term intranasal desmopressin acetate prophylaxis and avoidance of factor VIII concentrates (FVIIIc) in mild hemophilia a (mha) with high titer inhibitors (hti). Robbins D*, Kulkarni R, Gera R, Scott-Emuakpor A, Bosma K and Penner JA, Michigan State University, East Lansing, MI, USA. July 17, 2000 World Federation of Haemophilia, July 2000, Montreal.
  44. **Nondisclosure of HIV/HCV in a co-infected hemophilic male: medical and ethical dilemma. Kulkarni R, Scott-Emuakpor AB, Brody H, *Ragni MV, Weil WB, Gera R, Bosma K, Penner, JA, and the Center for Ethics and Humanities in the Life Sciences, Michigan State University, East Lansing, MI, USA and *University of Pittsburgh, PA, USA. July 19, 2000 World Federation of Haemophilia, July 2000, Montreal.
  45. **A 27 year follow up of persistent nephrogenic rests (NR), diffuse nephroblastomatosis (DNB) and Wilms tumor (WT) presenting with severe intrarenal fibrosis, infundibular stenosis and cystic renal dysplasia: natural progression or a consequence of treatment? Kulkarni R, Wolf Jr. JS, Padiyar N, Zuckerman L, Gera R, Scott-Emuakpor AB, and Cavanaugh E. American Society of Pediatric Hematology/Oncology, September 2000.
  46. **Transient acute renal failure (ARF) and intravascular hemolysis (IVH) following intravenous (IV) anti-D treatment of immune thrombocytopenia (ITP). Gera R, Kulkarni R, Scott-Emuakpor AB. Michigan State University, Pediatrics/Human Development, East Lansing, MI. American Society of Pediatric Hematology/Oncology, September, 2000.
  47. *Safety and efficacy of a novel IGIV preparation in the treatment of ITP. Bussel J. Eldor A, Liat N, Kelton J, Varon D, Angiolilo A, Brenner B, Abshire T, Gillis S, Kulkarni R, Lemm G and the ITP Study Group. ISTH July 2000
  48. **Rapidly advancing proptosis in a four-year old child with HIV infection. Patterson MN, Elliott M, Kulkarni R, Gera, R. Fifth International AIDS Malignancy Conference, Bethesda, 2001.
  49. **Olomu N, Kulkarni R, Manco- Johnson M. Treatment of intrapulmonary hemorrhage with activated recombinant Factor VII (rFVIIa) in very low birth weight (VLBW) infants on mechanical ventilation in a community level III neonatal intensive care unit (NICU). Presented as a poster American Society of Hematology 2001. Blood 2001;98: 262A-263A.
  50. **Kulkarni R, Daneshmand A, Guertin S, Fath J, Atwal J, Melvin J, LaFrance Successful use of recombinant factor VIIa (rFVIIa) in traumatic liver injuries in children. Poster Presented at the American Society of Pediatric Hematology/Oncology, Baltimore. May 5, 2002.
  51. **Kulkarni R, Daneshmand A, Guertin S, Fath J, Atwal J, Melvin J, LaFrance Successful use of recombinant factor VIIa (rFVIIa) in traumatic liver injuries in children. World Federation of Hemophilia, Seville Spain, May 20, 2002. Published in Hemophilia, 2002, 8, page 492.
  52. **ADHD in 6-14 year old hemophilia population pilot study. Merritt D, McGinty L, Palazzolo V, Adkins S, Bosma K, Munn J, Gera R, Kulkarni R, Pipe S, Warrier I. World Federation of Haemophilia, Seville Spain May 2002. Published in Hemophilia, 2002, 8, page 492.
  53. **Kulkarni R, Soucie M, Evatt BL and the Hemophilia Surveillance System Project Investigators. Renal disease among males with hemophilia. Presented poster at the American Society of Hematology meeting, Philadelphia 2002. Abstract No. 1919. Blood 2002;100 (11): 493a.
  54. Kulkarni R, Reddy UM, Evatt BL. How does blood clot? Physiology of hemostasis: Clotting pathways, platelets, endothelium, and cell based coagulation: A novel teaching tool using computer based animation. Blood 2002; 100 (11): 501b.
  55. Gera R, Kulkarni R, Scott-Emuakpor AB, Netzloff M. Carnitine replacement for symptomatic hypoglycemia in a patient with Acute Lymphoblastic Leukemia. Submitted to American Society of Pediatric Hematology/Oncology, May, 2003.
  56. Gera R, Gulnar C, Scott-Emuakpor AB, Kulkarni R. Vasoocclusive crises in sickle hemoglobin E (SE) disease. Submitted to American Society of Pediatric Hematology/Oncology, May, 2003.
  57. *Michael Tarantino, Guy Young, Salvatore Bertolone, Karen Kalinyak, Frank Shafer, Roshni Kulkarni, Diane Nugent High-dose Anti-D Immune Globulin Raises the Platelet Count in Newly Diagnosed Severe Childhood Immune Thrombocytopenic Purpura (ITP) More Rapidly than Standard-Dose Anti-D and Higher than IVIg. Presented at ASPHO 2003, Seattle May 4th 2003.
  58. **Olomu IN1+, Omar S1, Kulkarni R1, Hong T2 and Chamyan G3. Cerebral Infarction and Placental Pathology in Term Newborn Infants. Poster presentation Research day Department of Pediatrics and Human Development. Michigan State University. May 30th, 2003.
  59. **Vyas H, Guertin S, Fath J, Kulkarni R.Use of Recombinant Activated Factor VII (rFVIIa) In Severe Bleeding Episodes in Children- A Retrospective Study. Poster presentation Research day Department of Pediatrics and Human Development. Michigan State University. May 30th, 2003.
  60. **Kulkarni R, Soucie M, Evatt BL and the Hemophilia Surveillance System Project Investigators. Renal disease among males with hemophilia. International Society of Thrombosis and Hemostasis 2003, Birmingham UK, July 15, 2003.
  61. **Kulkarni R, Soucie M, Evatt BL and the Hemophilia Surveillance System Project Investigators. Heart disease among males with hemophilia. International Society of Thrombosis and Hemostasis 2003, Birmingham UK, July 15, 2003.
  62. Vyas H, Kulkarni R, Guertin S, Fath J,. Recombinant Activated Factor VII (rFVIIa) for the treatment of severe bleeding episodes in pediatric patients in a community hospital. Abstract No. 4107. Blood 2003;102 (11): 100b.
  63. Tarantino MD, Young G, Bertolone SJ, Shafer FE, Kulkarni R, Weber LC, Nugent DJ and the Acute ITP study group. High-dose Anti-D Immune Globulin is As Effective as IVIg in The Treatment Of Newly Diagnosed Immune Thrombocytopenic Purpura (ITP) in children. Presented at the American Society of Hematology Dec. 2003 Annual meeting. Abstract No. 1072. Blood 2003;102 (11): 299a.
  64. Tarantino MD, Young G, Bertolone SJ, Kalinyak K, Shafer FE, Kulkarni R, Nugent DJ and the Acute ITP study group. High-dose Anti-D Immune Globulin Raises the Platelet Count in Newly Diagnosed Severe Childhood Immune Thrombocytopenic Purpura (ITP) More Rapidly than Standard-Dose Anti-D and Higher than IVIg. Presented at the 2003 Pediatric Academic Societies meeting Seattle Washington May 2003
  65. Olomu IN1+, Omar S1, Kulkarni R, Hong T and Chamyan G. Thrombophilia, Placental Pathology and Cerebral Infarction in Term Newborn Infants Presented at the American Society of Hematology Dec. 2003 Annual meeting. Abstract No. 2021. Blood 2003;102 (11): 550a.

Submitted abstracts:

  1. Effectiveness of Recombinant activated FVII (rFVIIa) for the treatment of severe bleeding episodes in pediatric patients in a community hospital. Vyas H, Kulkarni R, Guertin S, Fath J. Submitted to the International Society of Thrombosis and Hemostasis, 2005 Annual meeting.
  2. Thrombophilia, Placental Pathology and Perinatal Cerebral Infarction: Any Relationship? Olomu, IN, Omar SA, Hong, T, Chamyan, G, Kulkarni, R. Submitted to the International Society of Thrombosis and Hemostasis, 2005 Annual meeting.
  3. The Older Hemophilia Patient With Inhibitors: Issues and Challenges. R. Kulkarni, J. A. Penner, K. Bosma, R. Gera, A. Scott-Emuakpor. Submitted to the International Society of Thrombosis and Hemostasis, 2005 Annual meeting.
  4. Quality of Life (QoL) Evaluation in Women with Menorrhagia and Inherited Bleeding Disorders. Dowling, NF, Byams, VR, Miller, CH, Heit, JA, Kouides, PA, Philipp, CS, Stein, SF, Kulkarni, R, Lukes, A, Crudder, Submitted to the International Society of Thrombosis and Hemostasis, 2005 Annual meeting.
  5. Treatment and Management of Women with Bleeding Disorders and Menorrhagia (WBDM) Study: Laboratory Diagnosis. Miller, CH, Dowling, N, Heit JA, Kouides, PA, Philipp CS, Stein SF, Kulkarni R, Lukes A, Crudder S. Submitted to the International Society of Thrombosis and Hemostasis, 2005 Annual meeting.
  6. Multi-Site Comparison of Platelet Function Testing. Miller, CH, Dowling, N, Heit JA, Kouides, PA, Philipp CS, Stein SF, Kulkarni R, Lukes A, Crudder S. Submitted to the International Society of Thrombosis and Hemostasis, 2005 Annual meeting.
  7. Use of Becaplermin, a platelet derived growth factor, for rapid wound healing in pediatric oncology patients. Goldman M, Kulkarni R, Watkins L, Gera R, Scott-Emuakpor A. Submitted to the American Society of Pediatric Hematology Oncology annual meeting 2005.

Workshops

  1. Invited workshop : Interdisciplinary forum: Clinical Perspectives of Emerging Pathogens in Bleeding Disorders Eric P. Newman Center, Washington University, St. Louis, Missouri June 5-6, 2004
  2. Invited workshop "How does blood clot". World Federation of Hemophilia Bangkok, 2004
  3. Invited workshop "How to develop and use animations and digital collaboration as teaching tools: New horizons in teaching generation X" at the Pediatric Academic Societies meetings, May 2rd San Francisco 2004.
  4. "How to develop and use animations and digital collaboration as teaching tools: New horizons in teaching generation X" at the Pediatric Academic Societies meetings, May 3rd Seattle WA 2003.

Moderator

  1. Hemophilia and Thrombosis Research Society session at the National Hemophilia foundation Meeting Salt Lake City Nov 2003.
  2. Baxter symposium on The Latest Advancement in Hemophilia A Therapy: The First and Only Plasma/Albumin-free Recombinant Antihemophilic FVIII: Advate (rAHF-PFM). National Hemophilia Foundation meeting Salt Lake City Nov 2003.

Text book chapters:

  1. ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  2. Kulkarni R. Gera R, Scott-Emuakpor AB: Adolescent Hematology. ESSENTIALS IN ADOLESCENT MEDICINE. Editors Hofmann AD and Greydanus DE. McGraw Hill 2004
  3. Kulkarni R and Lusher J. Treatment of Congenital Coagulopathies in TRANSFUSION THERAPY: CLINICAL PRINCIPLES AND PRACTICE, 2ND EDITION. Mintz PD, ed. AABB press, Bethesda Maryland. Pages 121-157. 2005
  4. Lusher J and Kulkarni R. Hereditary and acquired coagulation disorders. Chapter 11. TRANSFUSION MEDICINE IN PRACTICE. Editors: Duguid J, Goodnough LT, Desmond MJ. Martin Dunitz publishers, London U.K. 2002.
  5. Gera R, Kulkarni R. Venous Thromboembolism. IN S. Gupta (ed.), RECENT ADVANCES IN PEDIATRICS. Special Volume 8, Emergency Medicine, pp. 230-238, 2001, Jaypee Brothers Medical Publishers LTD, New Delhi.
  6. Kulkarni, R., Gera, R., Penner, J.A.: Hemophilia and Other Inherited Coagulation Disorders IN Rex B. Conn (ed), CURRENT DIAGNOSIS 605-611, 1991, W.B. Saunders Company.
  7. R. Gera, R. Kulkarni, A.B. Scott-Emuakpor: Hemorrhage, Shock and Disseminated Intravascular Coagulopathy IN Donnellan, W.L., Kimura, K, and Soper, R.T. (eds.), ABDOMINAL SURGERY OF INFANCY AND CHILDHOOD, pp.4/1 - 4/17, 1996, Harwood Academic Publishers.
 
Updated: May 9, 2006